SWISS pharmaceutical giant Roche announced to cooperate with Ascletis, a bio-tech company in Zhejiang Province, to jointly develop and commercialize Roche's hepatitis C medicine, danoprevir, in China. It will be the first antiviral drug for hepatitis ...
[Published Shanghai Daily - Apr 16 2013]